Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q3 EPS of ($0.30), $0.05 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.23 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.